Deep Brain Stimulation Beneficial in Severe Tourette's

This article originally appeared here.
Share this content:
Deep Brain Stimulation Beneficial in Severe Tourette's
Deep Brain Stimulation Beneficial in Severe Tourette's

WEDNESDAY, April 12, 2017 (HealthDay News) -- Some young patients with severe cases of Tourette's syndrome (TS) may benefit from deep brain stimulation (DBS), according to a study published online April 7 in the Journal of Neurosurgery.

Alon Mogilner, M.D., Ph.D., the senior researcher on the study, and his colleagues at the New York University Langone Medical Center in New York City have been able to offer DBS to certain teenage and young adult patients on an investigational basis. A committee of independent specialists reviews each case, to make sure the patient has tried standard therapies and is a good candidate for DBS. The new study reviewed the outcomes of 13 of those patients -- who were followed for an average of two years after having the surgery.

On average, the researchers found, the patients were reporting a 50 percent improvement in tic severity at their most recent follow-up visit. While DBS did not eliminate their symptoms, it made a difference in their quality of life, according to Mogilner. The relief was enough, for instance, to allow some adolescents who'd been home-schooled to go back to school, he told HealthDay. Two patients did experience complications -- including a scalp infection and a wire breakage -- that required some of the DBS hardware to be replaced. Still, the procedure was generally safe, Mogilner said.

"The authors' data are consistent with the small but growing body of literature supporting DBS of the ventralis oralis internus/centromedian-parafascicular thalamus as an effective and relatively safe treatment for severe, refractory TS," the study concludes.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Clinical Evidence Synopsis Published for T2DM

Clinical Evidence Synopsis Published for T2DM

Adding sulfonylurea or metformin to insulin decreases HbA1c about 1%

Lifestyle, Metformin Interventions Have Variable Effects

Lifestyle, Metformin Interventions Have Variable Effects

Impact of interventions varies for progression to diabetes, regression to normal glucose regulation

PPI Use Linked to Increased Risk of Ischemic Stroke, MI

PPI Use Linked to Increased Risk of Ischemic ...

Risks of first-time stroke, myocardial infarction up especially for long-term users, at high doses

is free, fast, and customized just for you!

Already a member?

Sign In Now »